HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Conservative management of senile cataract with conjunctisan A eye drops].

Abstract
It seems to be a generally held view that there is no way of treating senile cataract successfully. However, this view is contradicted by the results of a long-term study carried out on 192 eyes treated with Conjunctisan A. According to these results lens opacities in senile cataract can indeed be influenced by therapy. Conjunctisan is a new therapeutic principle which exploits the effect of watersoluble protoplasmic elements, in particular proteins, ribonucleic and deoxyribonucleic acids, phospholipids, polysaccharides, lens-cell-specific nucleic acids and amino acid precursors from the lens, vitreous body, retina, optic nerve, cornea, conjunctiva and placenta. Over a period of observation of 5 years (1973-1978) Conjunctisan A eye drops were administered to the conjunctival sac twice or three times a day. Out of 192 eyes thus treated, lens opacification was halted in 36% and vision improved in 45%. These results concur with those of our earlier investigations on 74 eyes (1969-1973). It is also worth mentioning that opacification is slowed down much more than previously assumed on the basis of experience: this was demonstrated in a comparison with 75 cases of senile cataract that were not treated or treated only by conventional methods.
AuthorsJ Fuchs
JournalKlinische Monatsblatter fur Augenheilkunde (Klin Monbl Augenheilkd) Vol. 175 Issue 6 Pg. 799-805 (Dec 1979) ISSN: 0023-2165 [Print] Germany
Vernacular TitleDie konservative Behandlung des Altersstars mit Conjunctisan A Augentropfen.
PMID552005 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Drug Combinations
  • Eye Proteins
  • Ophthalmic Solutions
  • Proteins
  • Tissue Extracts
  • conjunctisan A
Topics
  • Aged
  • Cataract (drug therapy, physiopathology)
  • Drug Combinations (therapeutic use)
  • Eye Proteins
  • Humans
  • Lens, Crystalline (metabolism)
  • Ophthalmic Solutions
  • Proteins (therapeutic use)
  • Tissue Extracts (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: